Cobratoxin inhibits pain-evoked discharge of neurons in thalamic parafascicular nucleus in rats: involvement of cholinergic and serotonergic systems. 2009

Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
Department of Neurobiology and Medical Psychology, Medical College, Soochow University, Suzhou 215123, PR China.

The present study investigated the inhibitory effect of cobratoxin (CTX) on pain-evoked discharge of neurons in thalamic parafascicular nucleus (Pf) of rats and analyzed some of the mechanisms involved in this effect. Intracerebroventricular injection (icv) of CTX at 0.56, 1.12 and 4.50 microg/kg resulted in a dose-dependent inhibitory effect on the pain-evoked discharges of Pf neurons. The inhibition of pain-evoked discharges of Pf neurons by CTX at high dose (4.50 microg/kg) persisted at least for 2h, while the inhibitory effect of morphine (40 microg) persisted no longer than 30 min. The inhibitory effect of CTX was reversed by pretreatment with atropine (icv, 5 microg). In contrast, icv injection of naloxone (4 microg) had no effect on CTX-induced inhibition. Furthermore, pretreatment with parachlorophenylalanine, a specific inhibitor of tryptophan hydroxylase, also significantly attenuated the inhibitory effect of CTX. The results suggested that: (a) CTX has a dose-dependent inhibitory effect on pain-evoked discharges of Pf neurons, confirming electrophysiologically the antinociceptive action of CTX; (b) the inhibitory effect of CTX has a longer duration compared to that of morphine; (c) central cholinergic and serotonergic systems, but not opioidergic system, are involved in the inhibitory effect of CTX.

UI MeSH Term Description Entries
D008297 Male Males
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D003039 Cobra Neurotoxin Proteins Toxins, contained in cobra (Naja) venom that block cholinergic receptors; two specific proteins have been described, the small (short, Type I) and the large (long, Type II) which also exist in other Elapid venoms. Cobra Neurotoxins,Cobrotoxin,Neurotoxin Proteins, Cobra,Neurotoxins, Cobra,Proteins, Cobra Neurotoxin
D005071 Evoked Potentials Electrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported. Event Related Potential,Event-Related Potentials,Evoked Potential,N100 Evoked Potential,P50 Evoked Potential,N1 Wave,N100 Evoked Potentials,N2 Wave,N200 Evoked Potentials,N3 Wave,N300 Evoked Potentials,N4 Wave,N400 Evoked Potentials,P2 Wave,P200 Evoked Potentials,P50 Evoked Potentials,P50 Wave,P600 Evoked Potentials,Potentials, Event-Related,Event Related Potentials,Event-Related Potential,Evoked Potential, N100,Evoked Potential, N200,Evoked Potential, N300,Evoked Potential, N400,Evoked Potential, P200,Evoked Potential, P50,Evoked Potential, P600,Evoked Potentials, N100,Evoked Potentials, N200,Evoked Potentials, N300,Evoked Potentials, N400,Evoked Potentials, P200,Evoked Potentials, P50,Evoked Potentials, P600,N1 Waves,N2 Waves,N200 Evoked Potential,N3 Waves,N300 Evoked Potential,N4 Waves,N400 Evoked Potential,P2 Waves,P200 Evoked Potential,P50 Waves,P600 Evoked Potential,Potential, Event Related,Potential, Event-Related,Potential, Evoked,Potentials, Event Related,Potentials, Evoked,Potentials, N400 Evoked,Related Potential, Event,Related Potentials, Event,Wave, N1,Wave, N2,Wave, N3,Wave, N4,Wave, P2,Wave, P50,Waves, N1,Waves, N2,Waves, N3,Waves, N4,Waves, P2,Waves, P50
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001285 Atropine An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. AtroPen,Atropin Augenöl,Atropine Sulfate,Atropine Sulfate Anhydrous,Atropinol,Anhydrous, Atropine Sulfate,Augenöl, Atropin,Sulfate Anhydrous, Atropine,Sulfate, Atropine

Related Publications

Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
November 2011, Brain structure & function,
Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
August 2009, Neuroscience,
Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
August 2009, Journal of neurophysiology,
Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
December 2010, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
January 1988, Zhen ci yan jiu = Acupuncture research,
Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
May 2010, Journal of neural transmission (Vienna, Austria : 1996),
Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
October 2011, Acta pharmacologica Sinica,
Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
February 1986, Sheng li xue bao : [Acta physiologica Sinica],
Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
September 2013, European journal of pharmacology,
Bo-Chao Cheng, and Xi-Ping Zhou, and Qi Zhu, and Shan Gong, and Zheng-Hong Qin, and Paul F Reid, and Laurence N Raymond, and Qi-Zhang Yin, and Xing-Hong Jiang
February 1987, Sheng li xue bao : [Acta physiologica Sinica],
Copied contents to your clipboard!